| Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. DC Goff, C Cather, AE Evins, DC Henderson, O Freudenreich, ... Journal of Clinical Psychiatry 66 (2), 183-194, 2005 | 439 | 2005 |
| Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations O Freudenreich, DC Goff Acta Psychiatrica Scandinavica 106 (5), 323-330, 2002 | 348 | 2002 |
| Clozapine decreases smoking in patients with chronic schizophrenia. J McEvoy, O Freudenreich, M McGee, C Vanderzwaag, E Levin, J Rose Biological Psychiatry, 1995 | 306 | 1995 |
| The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls RS Barr, MA Culhane, LE Jubelt, RS Mufti, MA Dyer, AP Weiss, ... Neuropsychopharmacology 33 (3), 480-490, 2008 | 303 | 2008 |
| Haloperidol increases smoking in patients with schizophrenia JP McEvoy, O Freudenreich, ED Levin, JE Rose Psychopharmacology 119 (1), 124-126, 1995 | 303 | 1995 |
| Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study DC Henderson, DD Nguyen, PM Copeland, DL Hayden, CP Borba, ... Journal of Clinical Psychiatry 66 (9), 1116-1121, 2005 | 256 | 2005 |
| Smoking and therapeutic response to clozapine in patients with schizophrenia JP McEvoy, O Freudenreich, WH Wilson Biological Psychiatry 46 (1), 125-129, 1999 | 256 | 1999 |
| A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia AE Evins, C Cather, T Deckersbach, O Freudenreich, MA Culhane, ... Journal of clinical psychopharmacology 25 (3), 218-225, 2005 | 252 | 2005 |
| Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges. C VanderZwaag, M McGee, JP McEvoy, O Freudenreich, WH Wilson, ... The American journal of psychiatry 153 (12), 1579-1584, 1996 | 218 | 1996 |
| A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia DC Goff, JS Lamberti, AC Leon, MF Green, AL Miller, J Patel, ... Neuropsychopharmacology 33 (3), 465-472, 2008 | 209 | 2008 |
| A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia AE Evins, C Cather, MA Culhane, A Birnbaum, J Horowitz, E Hsieh, ... Journal of clinical psychopharmacology 27 (4), 380-386, 2007 | 209 | 2007 |
| Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight O Freudenreich, C Cather, AE Evins, DC Henderson, DC Goff Journal of Clinical Psychiatry 65 (10), 1372-1376, 2004 | 194 | 2004 |
| Folate, homocysteine, and negative symptoms in schizophrenia DC Goff, T Bottiglieri, E Arning, V Shih, O Freudenreich, AE Evins, ... American Journal of Psychiatry 161 (9), 1705-1708, 2004 | 184 | 2004 |
| Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia X Fan, C Pristach, EY Liu, O Freudenreich, DC Henderson, DC Goff Psychiatry research 149 (1-3), 267-271, 2007 | 178 | 2007 |
| An exploratory open‐label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia DC Henderson, L Kunkel, DD Nguyen, CP Borba, TB Daley, PM Louie, ... Acta Psychiatrica Scandinavica 113 (2), 142-147, 2006 | 176 | 2006 |
| Dietary intake profile of patients with schizophrenia DC Henderson, CP Borba, TB Daley, R Boxill, DD Nguyen, MA Culhane, ... Annals of clinical psychiatry 18 (2), 99-105, 2006 | 173 | 2006 |
| A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain DC Henderson, PM Copeland, TB Daley, CP Borba, C Cather, ... American Journal of Psychiatry 162 (5), 954-962, 2005 | 173 | 2005 |
| Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial O Freudenreich, DC Henderson, JP Walsh, MA Culhane, DC Goff Schizophrenia research 92 (1-3), 90-94, 2007 | 165 | 2007 |
| The syndemic illness of HIV and trauma: implications for a trauma-informed model of care C Brezing, M Ferrara, O Freudenreich Psychosomatics 56 (2), 107-118, 2015 | 162 | 2015 |
| Consensus statement on the use of clozapine during the COVID-19 pandemic D Siskind, WG Honer, S Clark, CU Correll, A Hasan, O Howes, JM Kane, ... Journal of Psychiatry and Neuroscience 45 (3), 222-223, 2020 | 152 | 2020 |
